The 20 Best Rhabdoid Tumor Doctors Near Me in District of Columbia, US

Jeffrey Dome, MD, PhD, is senior vice president of the Cancer and Blood Disorders Center at Children’s National Hospital in Washington, D.C. He is professor of pediatrics at the George Washington University School of Medicine and Health Sciences and the Thomas Willson and Lenore Williams McKnew professor of pediatric oncology. Dr. Dome received his medical degree from the University of Pennsylvania School of Medicine and PhD degree in medicine from Erasmus University in Rotterdam. He completed a residency in pediatrics at Yale-New Haven Hospital and completed a fellowship in pediatric hematology/oncology at Johns Hopkins Hospital. After fellowship, Dr. Dome was a faculty member at St. Jude Children’s Research Hospital before joining Children’s National in 2006. Dr. Dome is an internationally recognized expert on pediatric solid tumors, with an emphasis on kidney tumors and sarcomas. He chaired the Children’s Oncology Group (COG) Renal Tumor Committee for more than a decade. He is presently on the Scientific Council of the COG, the editorial board of Pediatric Blood and Cancer, and is past chair of the American Board of Pediatrics Subboard of Hematology/Oncology. Dr. Dome serves on numerous medical advisory boards for cancer foundations and currently is the North American Continental President of the International Society of Pediatric Oncology (SIOP). He has authored more than 200 articles, books, letters and chapters on pediatric cancer. Dr. Dome is rated as a Distinguished provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Denys-Drash Syndrome (DDS), Adult Soft Tissue Sarcoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Dome is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 1998.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Advanced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy. Dr. Boudadi is board certified in American Board Of Internal Medicine.

Dennis Priebat is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Priebat is rated as a Distinguished provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, and Prostatectomy. Dr. Deville is board certified in American Board Of Radiology.

Dr. Jones is a radiologist and currently serves as the Chief of Ultrasound at Sibley Memorial Hospital. He received his B.S. from Stanford University and Medical degree from the University of Wisconsin-Madison. He completed a diagnostic residency at the National Naval Medical Center, followed by a Cross-sectional Imaging fellowship at Georgetown University Hospital. Prior to joining Johns Hopkins, Dr. Jones was a staff radiologist at Suburban and Sibley Memorial Hospitals from 2004-2016. He serves as vice chairman of the Sibley Memorial Hospital Department of Radiology. Dr. Jones has subspecialty expertise in abdominal CT, MRI, ultrasound and image-guided biopsies. Dr. Jones is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Collapsed Lung, Fecal Impaction, Pleurisy, and Pleural Effusion. Dr. Jones is board certified in American Board Of Radiology.

Monica Pearl, MD, is a board-certified American Board of Radiology diplomate with subspecialty fellowship training and certification in Diagnostic Neuroradiology and Interventional Neuroradiology. She is also a Professor of Radiology and Pediatrics at the George Washington University School of Medicine and Health Sciences. She received her undergraduate degree in mathematics from the University of North Carolina at Chapel Hill and her Doctor of Medicine from Duke University. Dr. Pearl trained in general surgery and diagnostic radiology at the George Washington University and completed fellowships in both Diagnostic Neuroradiology and Interventional Neuroradiology at the Johns Hopkins University, where she was on faculty from 2010 – 2020. Her career is dedicated to the care of children with neurovascular disorders, and she brings her expertise to Children’s National Hospital in the areas of cerebrovascular pathology, novel CNS drug delivery platforms and innovative endovascular therapies for CNS disorders including intractable seizures due to hemimegalencephaly. She has been the recipient of numerous research awards from private foundations as well as from state and federal (NIH) funding sources. Her research is focused on radiation dose reduction strategies and innovative endovascular therapies for pediatric tumors of the head, neck and spine. Dr. Pearl is a member of the American Society of Neuroradiology, a Senior Member of the Society of Neurointerventional Surgery and a member of the Core Steering Group for the Children’s Brain Tumour Drug Delivery Consortium, an international, multidisciplinary network of clinicians and researchers dedicated to developing drug delivery systems for children with brain tumors. Dr. Pearl is available for patient and physician consultation, image review, and sees patients at Children’s National in her clinic by appointment. Dr. Pearl is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Increased Head Circumference, Arteriovenous Malformation, Brain Aneurysm, Liver Embolization, and Thrombectomy. Dr. Pearl is board certified in Neuroradiology: American Board Of Radiology, 2012 and Diagnostic Radiology: American Board Of Radiology, 2008.

Jonathan Zember is a Pediatric Radiologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 15 years. Dr. Zember is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. His clinical expertise encompasses Marshall-Smith Syndrome, Perlman Syndrome, Cantu Syndrome, and Megalencephaly-Capillary Malformation Syndrome. Dr. Zember is board certified in Pediatric Radiology: American Board Of Radiology, 2019 and Diagnostic Radiology: American Board Of Radiology, 2017.

Robert Henshaw, MD, is the director of Orthopaedic Oncology at Children’s National Hospital. Dr. Henshaw is board-certified in orthopaedic surgery specializes in orthopaedic oncology. He is renowned for introducing minimally invasive procedures for children with bone tumors and performing cutting-edge limb sparing surgery for children with sarcomas (cancer of the musculoskeletal system) using a variety of innovative techniques including expandable implants for growing children. He is also a Professor of Orthopaedic Surgery at Georgetown University School of Medicine. Dr. Henshaw is rated as an Advanced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, Osteotomy, and Bone Graft. Dr. Henshaw is board certified in Orthopaedic Surgery: American Board Of Orthopaedic Surgery, 1999.

"Eugene (Gene) Hwang, MD, is chief of the Division of Oncology at Children’s National Hospital in Washington, D.C. He is also part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials focused on gene therapy and new, targeted agents. He is the site Principal Investigator of the Pediatric Brain Tumor Consortium, where he is the co-chair of the Immunotherapy Working Group. He serves on grant review committees and on the scientific advisory boards of several large foundations. For each patient, Dr. Hwang carefully considers the best possible options for treatment, trying new, cutting edge treatments coupled with the best available known therapies. Dr. Hwang is not only dedicated to finding a cure for cancer, but also to making the current treatments as safe as possible for children: ""We often focus on curing the children - that's the number one goal - but we also need to pay attention to the toxicity of these treatments, and what quality of life the children will have after treatment."" Dr. Hwang is involved in several international efforts to study how to best mitigate treatment side effects. In the meantime, Dr. Hwang makes sure he is doing everything he can to combat pain, dizziness, fatigue and other common side effects of cancer treatments by leveraging the multidisciplinary team approach of Children's National. He sees this as something the organization does exceptionally well, and thinks that having so many people focus on a single patient in a single visit is crucial to well-being during cancer treatment.". Dr. Hwang is rated as an Advanced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pineocytoma, Glioma, Medulloblastoma, and Pineoblastoma. Dr. Hwang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2005.

Erin O'neill is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. O'neill is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Retroversion of the Uterus, Gallbladder Disease, Ascites, and Pleurisy.

Jordan Gold is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. His clinical expertise encompasses Nasal Flaring, Tenosynovitis, Gas Bloat Syndrome, Diverticular Disease, and Bone Marrow Aspiration.

Michael Smith is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Nasal Flaring, Pleurisy, Pleural Effusion, and Ascites.

Matthew Freedman is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Freedman is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, Rhabdoid Tumor, Tissue Biopsy, and Prostatectomy.

Namik Haveric is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Haveric is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Pleurisy, Progressive Familial Intrahepatic Cholestasis Type 2, and Progressive Familial Intrahepatic Cholestasis Type 3.

Holly Meany, MD, is a pediatric oncologist and director of the Solid Tumor Program at Children’s National Hospital. She also serves as an associate professor of pediatrics at George Washington University. Dr. Meany is dedicated to finding better treatments for children with cancer through research and clinical care. Her work focuses on developing new therapies for pediatric solid tumors. She designs and leads early-phase clinical trials to test promising treatments and understand how they work in children. Dr. Meany has played a key role in several national studies, including large trials for neuroblastoma, a type of childhood cancer. She recently led an international study for children with newly diagnosed non-high-risk neuroblastoma and is currently helping to develop the next high-risk neuroblastoma trial, both through the Children’s Oncology Group. Dr. Meany is also exploring innovative approaches like immunotherapy—using the body’s own immune system to fight cancer. She has led international studies using specialized T cells to treat patients with relapsed solid tumors and is now working on combining these novel T cells with CAR T-cell therapy for children with relapsed cancers. In addition to her research, Dr. Meany is passionate about training the next generation of pediatric cancer specialists. As director of the Pediatric Hematology-Oncology Fellowship Program at Children’s National, she mentors and supports future leaders in the field. Dr. Meany is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Hereditary Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Osteosarcoma, and Mastoidectomy. Dr. Meany is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2006 and Pediatrics: American Board Of Pediatrics, 2003.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine.

Quyen Chu is a Surgical Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Pancreatic Cancer, Colorectal Cancer, Mastectomy, and Pancreatectomy.

Lindsay Kilburn, MD, comes to Children's National Hospital from Texas Children’s Hospital in Houston, TX, where she was an assistant professor of pediatrics in the neuro-oncology and pharmacology programs. Dr. Kilburn graduated with a degree in Environmental Sciences from the University of Virginia. After graduating from Eastern Virginia Medical School, she completed her pediatric training at the Children’s Hospital of The King’s Daughters in Norfolk, VA, and her hematology/oncology fellowship at Texas Children’s Hospital/Baylor College of Medicine in Houston, TX. She also has received training in pharmacology from both Thomas Jefferson University in Philadelphia and the Baylor College of Medicine in Houston. Dr. Kilburn is an associate professor, pediatrics at George Washington University School of Medicine. Her research focuses on the development and evaluation of new therapeutic agents for children with pediatric brain tumors through clinical trials. She is committed to the improvement of palliative and supportive care. Dr. Kilburn grew up outside of Philadelphia and is married with young twins. Outside of work, she enjoys sailing, hiking, and traveling with her family. Dr. Kilburn is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Optic Glioma. Dr. Kilburn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2004.

Brian R. Rood, MD, is the director of clinical neuro-oncology and the medical director of the Brain Tumor Institute at Children's National Hospital. Dr. Rood is also a principal investigator in the Center for Cancer and Immunology Research at Children's National Research Institute and a professor of pediatrics at the George Washington University School of Medicine and Health Sciences and adjunct professor at the Fralin Biomedical Research Institute at Virginia Tech. He received a Bachelor of Arts in English Literature from The Pennsylvania State University and completed medical school at Jefferson Medical College. He completed his pediatric residency training at the University of Vermont. Dr. Rood received his pediatric hematology/oncology training at Children's National. He joined the faculty of Children’s National in 2002 after completing a fellowship in pediatric hematology/oncology, as well as a research fellowship in the molecular biology of brain tumors, both at Children’s National and Children’s National Research Institute. Currently, Dr. Rood’s research focuses on the application of proteomics in cancer biology investigation, neoantigen identification and biomarker development. He has also been studying the contribution of germline microsatellite genotypes to pediatric brain tumor predisposition. He currently serves as the executive co-chair of the Children’s Brain Tumor Network, an international consortium of 28 institutions that maintains the world’s largest pediatric brain tumor tissue and data repository, which are freely provided to the research community to support the development of groundbreaking clinical trials through data-driven precision medicine. Dr. Rood has two children. His favorite pastimes include designing and building furniture, sailing, reading, and playing the mandolin. Dr. Rood is rated as an Experienced provider by MediFind in the treatment of Rhabdoid Tumor. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Rood is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1998.